Intrapleural and plasma processing of LTI-01 (single chain urokinase Plasminogen Activator, scuPA) in a phase 1b trial of LTI-01 Intrapleural Fibrinolytic Therapy (IPFT) in patients with Complicated Parapneumonic Effusions (CPE) or empyema

Intrapleural and plasma processing of LTI-01 (single chain urokinase Plasminogen Activator, scuPA) in a phase 1b trial of LTI-01 Intrapleural Fibrinolytic Therapy (IPFT) in patients with Complicated Parapneumonic Effusions (CPE) or empyema

Bibliographic Details
Main Authors: Komissarov, A, Florova, G, Beckert, L, Brockway, B, Simpson, G, Southcott, A, Lee, Y, Rahman, N, Light, R, Shoemaker, S, Gillies, J, Sarva, K, Idell, S
Format: Conference item
Published: American Thoracic Society 2019

Similar Items